शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ADVENZYMESBSEADVANCED ENZYME TECH LTD· Pharmaceuticals & BiotechnologyHighPositive
Announced Fri, 4 Sept, 2026 · 18:08 IST

Advanced Enzyme Tech buys back 55,332 shares at avg Rs 297.93

ADVENZYMES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.2%Reaction day
₹293.35
prior close
₹293.20
announcement price
After-mkt
timing
Nifty Microcap 250market+0.4%+0.8% vs market
Biotechnology peers, median of 5sector-0.4%+1.6% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 1.6 pts more than its Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.3
10m
-0.3
15m
-0.1
30m
+0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.2+0.4+0.8-0.4+1.6
Next day
+1.3+0.9+0.4+1.1+0.2
2d
+2.3+0.8+1.5+1.0+1.3
3d
+3.0+0.6+2.4+0.0+3.0
4d
+0.1+0.7-0.6+0.0+0.1
5d
-1.2-2.6+1.4+0.7-1.9
1w
-1.2-1.9+0.7-0.6-0.6
15d
-3.4-0.6-2.9-2.0-1.4
1m
-8.2-1.0-7.2-4.1-4.1
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Biotechnology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

On September 4, 2026, Advanced Enzyme Technologies bought back 55,332 equity shares through NSE at an average price of Rs 297.93 per share via broker Emkay Global. Cumulative shares bought back now total 10,28,788. This is part of the company's ongoing open market buyback programme under SEBI Buyback Regulations.

Likely market impact

Ongoing buyback signals management confidence in valuation and supports the share price while reducing equity dilution.